0.00Open0.15Pre Close0 Volume16 Open Interest7.50Strike Price0.00Turnover176.32%IV50.27%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier25DDays to Expiry0.15Extrinsic Value100Contract SizeAmericanOptions Type-0.0444Delta0.0137Gamma98.53Leverage Ratio-0.0125Theta-0.0005Rho-4.38Eff Leverage0.0036Vega
Wave Life Sciences Stock Discussion
Wave Life Sciences Announces First-Ever Therapeutic Rna Editing in Humans Achieved in Restoraation-2 Trial of Wve-006 in Alpha-1 Antitrypsin Deficiency
Wave Life Sciences Ltd: Expects to Share Multidose Data From Restoraation-2 Trial in 2025
In a notable transaction, GSK (LON:GSK) plc, a major player in the pharmaceutical industry, has recently increased its stake in Wave Life Sciences Ltd . (NASDAQ:WVE). The acquisition involved the purchase of 2,791,930 ordinary shares at a price of $8.00 per share, amounting to a total investment of $22.3 million.
This strategic move by GSK plc, which is known for its diverse portfolio of healthca...
No comment yet